 |
 |
 |
FDA
Home Page | Search FDA Site |
FDA A-Z Index | Contact FDA
Ethics and Risk Assessment [PowerPoint
[1.21 MB)]
Presented: April 17, 2007, to Drug Information Association in London, England
Presenter: Robert 'Skip' Nelson, M.D., Ph.D., Pediatric Bioethicist
Text version
Update: USA Pediatric Drug Development [PowerPoint
[1.19 MB)]
Presented: March 28, 2007, to Drug Information Association in Vienna, Austria
Presenter: Dianne Murphy, M.D., Director
Text version
Pediatric Drug Development: What have we learned? [PowerPoint [1.83 MB)]
Presented: June 13, 2006, to the Institute of Medicine National Academies
Presenter:
Dianne Murphy, M.D., director
Text version
Growth and Development of Pediatric Drug Development at the FDA [PowerPoint (1.68 MB)]
Presented: June 13, 2006, to the Institute of Medicine National Academies
Presenter: Lisa Mathis, M.D.
Text version
What We Have Learned from the Study of Drugs under the Pediatric Initiatives
[PowerPoint (1.35 MB)]
Presented: June 13, 2006, to the Institute of Medicine National Academies
Presenter: William Rodriguez, M.D., Ph.D.
Text version
Impact of Pediatric Legislative
Initiatives: USA (PowerPoint)
Presented: January 26, 2005, to the European Forum for Good Clinical Practice
Presenter: Dianne Murphy, M.D., director
Text version
Pediatric Issues in Clinical
Trials (PowerPoint)
Presented: August 26, 2004, in Rochester, MN
Presenter: Dianne Murphy, M.D., director
Text version
Special
Ethical Protections for Pediatric Research Participants: Subpart D and Assent (PowerPoint)
Presented: June 30, 2004. Adapted from Children's National Medical
Center/George Washington University Joint Grand Rounds (CNMC/GWU)
Presenter: Sara F. Goldkind, MD, MA, bioethicist
Text version
Microsoft PowerPoint presentations can be viewed with that application or with a viewer available free from the Microsoft Website. If you need additional information about viewing these files, please consult General Help for Accessing Files.